Css LLC Vertex Pharmaceuticals Inc Transaction History

Css LLC

$1.04 Billion
Q4 2024

A detailed history of Css LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Css LLC holds 550 shares of VRTX stock, worth $266,651. This represents 0.02% of its overall portfolio holdings.

Number of Shares

550

Previous 1,000 45.0%

Holding current value

$266,651

Previous $465,000 52.47%

% of portfolio

0.02%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$396.64 - $516.74 $178,488 - $232,533	-450 Reduced 45.0%	550 $221,000
Q3 2024 Nov 14, 2024	BUY	$460.0 - $505.78 $138,000 - $151,734	300 Added 42.86%	1,000 $465,000
Q1 2024 May 15, 2024	SELL	$407.69 - $446.08 $7.34 Million - $8.03 Million	-18,000 Reduced 96.26%	700 $292,000
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $102,900 - $123,204	-300 Reduced 1.58%	18,700 $7.61 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $101,454 - $108,738	-300 Reduced 1.55%	19,000 $6.61 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $408,746 - $457,483	1,300 Added 7.22%	19,300 $6.79 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $3.78 Million - $4.31 Million	13,336 Added 285.93%	18,000 $5.67 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $290,617 - $326,945	1,017 Added 27.89%	4,664 $1.35 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $37,240 - $41,552	-136 Reduced 3.6%	3,647 $1.06 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $266,444 - $331,751	1,134 Added 42.81%	3,783 $1.07 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $254,411 - $299,854	1,149 Added 76.6%	2,649 $691,000
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $8.42 Million - $10.6 Million	-47,560 Reduced 96.94%	1,500 $329,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $3.04 Million - $3.4 Million	16,744 Added 51.81%	49,060 $8.9 Million
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $6.06 Million - $7.15 Million	32,316 New	32,316 $6.52 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $135,288 - $177,480	-600 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $119,862 - $148,686	600 New	600 $143,000

Others Institutions Holding VRTX

# of Institutions

1,774

Shares Held

224M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $124B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

News

Stay updated on Css LLC with notifications on news.

Account